ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravitreal (IVT) Injectables Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-36T7198
Home | Market Reports | Health| Vision Care
Global Intravitreal IVT Injectables Market Insights Forecast to 2028
BUY CHAPTERS

Global Intravitreal (IVT) Injectables Market Research Report 2025

Code: QYRE-Auto-36T7198
Report
August 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Regeneron Pharmaceuticals
Bausch & Lomb
Novartis
Allergan plc
Alimera Sciences
ThromboGenics NV
Bristol–Myers Squibb
Bausch & Lomb

Intravitreal (IVT) Injectables Market Size

The global market for Intravitreal (IVT) Injectables was valued at US$ 16470 million in the year 2024 and is projected to reach a revised size of US$ 25100 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Intravitreal (IVT) Injectables Market

Intravitreal (IVT) Injectables Market

Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravitreal (IVT) Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal (IVT) Injectables.
The Intravitreal (IVT) Injectables market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravitreal (IVT) Injectables market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravitreal (IVT) Injectables manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravitreal (IVT) Injectables Market Report

Report Metric Details
Report Name Intravitreal (IVT) Injectables Market
Accounted market size in year US$ 16470 million
Forecasted market size in 2031 US$ 25100 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Regeneron Pharmaceuticals, Bausch & Lomb, Novartis, Allergan, Alimera Sciences, ThromboGenics, Bristol-Myers Squibb
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intravitreal (IVT) Injectables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intravitreal (IVT) Injectables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Intravitreal (IVT) Injectables Market growing?

Ans: The Intravitreal (IVT) Injectables Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Intravitreal (IVT) Injectables Market size in 2031?

Ans: The Intravitreal (IVT) Injectables Market size in 2031 will be US$ 25100 million.

What is the market share of major companies in Intravitreal (IVT) Injectables Market?

Ans: Global top five manufacturers hold a share over 70%.

What is the Intravitreal (IVT) Injectables Market share by region?

Ans: North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.

What is the Intravitreal (IVT) Injectables Market share by type?

Ans: In terms of drug, Anti-VEGF is the largest segment, with a share over 85%.

Who are the main players in the Intravitreal (IVT) Injectables Market report?

Ans: The main players in the Intravitreal (IVT) Injectables Market are Regeneron Pharmaceuticals, Bausch & Lomb, Novartis, Allergan, Alimera Sciences, ThromboGenics, Bristol-Myers Squibb

What are the Application segmentation covered in the Intravitreal (IVT) Injectables Market report?

Ans: The Applications covered in the Intravitreal (IVT) Injectables Market report are Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Others

What are the Type segmentation covered in the Intravitreal (IVT) Injectables Market report?

Ans: The Types covered in the Intravitreal (IVT) Injectables Market report are Anti-VEGF, Corticosteroids, Antibiotics, Antivirals, Antifungals

Recommended Reports

Ophthalmic Drug Markets

Retina Disease Treatments

Injectable & Delivery Devices

1 Intravitreal (IVT) Injectables Market Overview
1.1 Product Definition
1.2 Intravitreal (IVT) Injectables by Type
1.2.1 Global Intravitreal (IVT) Injectables Market Value Comparison by Type (2024 VS 2031)
1.2.2 Anti-VEGF
1.2.3 Corticosteroids
1.2.4 Antibiotics
1.2.5 Antivirals
1.2.6 Antifungals
1.3 Intravitreal (IVT) Injectables by Application
1.3.1 Global Intravitreal (IVT) Injectables Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Mail Order Pharmacies
1.3.6 Others
1.4 Global Intravitreal (IVT) Injectables Market Size Estimates and Forecasts
1.4.1 Global Intravitreal (IVT) Injectables Revenue 2020-2031
1.4.2 Global Intravitreal (IVT) Injectables Sales 2020-2031
1.4.3 Global Intravitreal (IVT) Injectables Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravitreal (IVT) Injectables Market Competition by Manufacturers
2.1 Global Intravitreal (IVT) Injectables Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intravitreal (IVT) Injectables Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intravitreal (IVT) Injectables Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravitreal (IVT) Injectables, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravitreal (IVT) Injectables, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravitreal (IVT) Injectables, Product Type & Application
2.7 Global Key Manufacturers of Intravitreal (IVT) Injectables, Date of Enter into This Industry
2.8 Global Intravitreal (IVT) Injectables Market Competitive Situation and Trends
2.8.1 Global Intravitreal (IVT) Injectables Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravitreal (IVT) Injectables Players Market Share by Revenue
2.8.3 Global Intravitreal (IVT) Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravitreal (IVT) Injectables Market Scenario by Region
3.1 Global Intravitreal (IVT) Injectables Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravitreal (IVT) Injectables Sales by Region: 2020-2031
3.2.1 Global Intravitreal (IVT) Injectables Sales by Region: 2020-2025
3.2.2 Global Intravitreal (IVT) Injectables Sales by Region: 2026-2031
3.3 Global Intravitreal (IVT) Injectables Revenue by Region: 2020-2031
3.3.1 Global Intravitreal (IVT) Injectables Revenue by Region: 2020-2025
3.3.2 Global Intravitreal (IVT) Injectables Revenue by Region: 2026-2031
3.4 North America Intravitreal (IVT) Injectables Market Facts & Figures by Country
3.4.1 North America Intravitreal (IVT) Injectables Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravitreal (IVT) Injectables Sales by Country (2020-2031)
3.4.3 North America Intravitreal (IVT) Injectables Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravitreal (IVT) Injectables Market Facts & Figures by Country
3.5.1 Europe Intravitreal (IVT) Injectables Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravitreal (IVT) Injectables Sales by Country (2020-2031)
3.5.3 Europe Intravitreal (IVT) Injectables Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravitreal (IVT) Injectables Market Facts & Figures by Region
3.6.1 Asia Pacific Intravitreal (IVT) Injectables Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravitreal (IVT) Injectables Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravitreal (IVT) Injectables Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravitreal (IVT) Injectables Market Facts & Figures by Country
3.7.1 Latin America Intravitreal (IVT) Injectables Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravitreal (IVT) Injectables Sales by Country (2020-2031)
3.7.3 Latin America Intravitreal (IVT) Injectables Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravitreal (IVT) Injectables Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravitreal (IVT) Injectables Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravitreal (IVT) Injectables Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravitreal (IVT) Injectables Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intravitreal (IVT) Injectables Sales by Type (2020-2031)
4.1.1 Global Intravitreal (IVT) Injectables Sales by Type (2020-2025)
4.1.2 Global Intravitreal (IVT) Injectables Sales by Type (2026-2031)
4.1.3 Global Intravitreal (IVT) Injectables Sales Market Share by Type (2020-2031)
4.2 Global Intravitreal (IVT) Injectables Revenue by Type (2020-2031)
4.2.1 Global Intravitreal (IVT) Injectables Revenue by Type (2020-2025)
4.2.2 Global Intravitreal (IVT) Injectables Revenue by Type (2026-2031)
4.2.3 Global Intravitreal (IVT) Injectables Revenue Market Share by Type (2020-2031)
4.3 Global Intravitreal (IVT) Injectables Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravitreal (IVT) Injectables Sales by Application (2020-2031)
5.1.1 Global Intravitreal (IVT) Injectables Sales by Application (2020-2025)
5.1.2 Global Intravitreal (IVT) Injectables Sales by Application (2026-2031)
5.1.3 Global Intravitreal (IVT) Injectables Sales Market Share by Application (2020-2031)
5.2 Global Intravitreal (IVT) Injectables Revenue by Application (2020-2031)
5.2.1 Global Intravitreal (IVT) Injectables Revenue by Application (2020-2025)
5.2.2 Global Intravitreal (IVT) Injectables Revenue by Application (2026-2031)
5.2.3 Global Intravitreal (IVT) Injectables Revenue Market Share by Application (2020-2031)
5.3 Global Intravitreal (IVT) Injectables Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Regeneron Pharmaceuticals
6.1.1 Regeneron Pharmaceuticals Company Information
6.1.2 Regeneron Pharmaceuticals Description and Business Overview
6.1.3 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product Portfolio
6.1.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.2 Bausch & Lomb
6.2.1 Bausch & Lomb Company Information
6.2.2 Bausch & Lomb Description and Business Overview
6.2.3 Bausch & Lomb Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bausch & Lomb Intravitreal (IVT) Injectables Product Portfolio
6.2.5 Bausch & Lomb Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Intravitreal (IVT) Injectables Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Company Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Allergan Intravitreal (IVT) Injectables Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Alimera Sciences
6.5.1 Alimera Sciences Company Information
6.5.2 Alimera Sciences Description and Business Overview
6.5.3 Alimera Sciences Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Alimera Sciences Intravitreal (IVT) Injectables Product Portfolio
6.5.5 Alimera Sciences Recent Developments/Updates
6.6 ThromboGenics
6.6.1 ThromboGenics Company Information
6.6.2 ThromboGenics Description and Business Overview
6.6.3 ThromboGenics Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ThromboGenics Intravitreal (IVT) Injectables Product Portfolio
6.6.5 ThromboGenics Recent Developments/Updates
6.7 Bristol-Myers Squibb
6.7.1 Bristol-Myers Squibb Company Information
6.7.2 Bristol-Myers Squibb Description and Business Overview
6.7.3 Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bristol-Myers Squibb Intravitreal (IVT) Injectables Product Portfolio
6.7.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravitreal (IVT) Injectables Industry Chain Analysis
7.2 Intravitreal (IVT) Injectables Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravitreal (IVT) Injectables Production Mode & Process Analysis
7.4 Intravitreal (IVT) Injectables Sales and Marketing
7.4.1 Intravitreal (IVT) Injectables Sales Channels
7.4.2 Intravitreal (IVT) Injectables Distributors
7.5 Intravitreal (IVT) Injectables Customer Analysis
8 Intravitreal (IVT) Injectables Market Dynamics
8.1 Intravitreal (IVT) Injectables Industry Trends
8.2 Intravitreal (IVT) Injectables Market Drivers
8.3 Intravitreal (IVT) Injectables Market Challenges
8.4 Intravitreal (IVT) Injectables Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Regeneron Pharmaceuticals
Bausch & Lomb
Novartis
Allergan plc
Alimera Sciences
ThromboGenics NV
Bristol–Myers Squibb
Bausch & Lomb
List of Tables
 Table 1. Global Intravitreal (IVT) Injectables Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intravitreal (IVT) Injectables Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intravitreal (IVT) Injectables Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intravitreal (IVT) Injectables Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intravitreal (IVT) Injectables Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intravitreal (IVT) Injectables Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intravitreal (IVT) Injectables Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intravitreal (IVT) Injectables Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intravitreal (IVT) Injectables, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intravitreal (IVT) Injectables, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intravitreal (IVT) Injectables, Product Type & Application
 Table 12. Global Key Manufacturers of Intravitreal (IVT) Injectables, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intravitreal (IVT) Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal (IVT) Injectables as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intravitreal (IVT) Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intravitreal (IVT) Injectables Sales by Region (2020-2025) & (K Units)
 Table 18. Global Intravitreal (IVT) Injectables Sales Market Share by Region (2020-2025)
 Table 19. Global Intravitreal (IVT) Injectables Sales by Region (2026-2031) & (K Units)
 Table 20. Global Intravitreal (IVT) Injectables Sales Market Share by Region (2026-2031)
 Table 21. Global Intravitreal (IVT) Injectables Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intravitreal (IVT) Injectables Revenue Market Share by Region (2020-2025)
 Table 23. Global Intravitreal (IVT) Injectables Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intravitreal (IVT) Injectables Revenue Market Share by Region (2026-2031)
 Table 25. North America Intravitreal (IVT) Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intravitreal (IVT) Injectables Sales by Country (2020-2025) & (K Units)
 Table 27. North America Intravitreal (IVT) Injectables Sales by Country (2026-2031) & (K Units)
 Table 28. North America Intravitreal (IVT) Injectables Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intravitreal (IVT) Injectables Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intravitreal (IVT) Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intravitreal (IVT) Injectables Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Intravitreal (IVT) Injectables Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Intravitreal (IVT) Injectables Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intravitreal (IVT) Injectables Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intravitreal (IVT) Injectables Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intravitreal (IVT) Injectables Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Intravitreal (IVT) Injectables Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Intravitreal (IVT) Injectables Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intravitreal (IVT) Injectables Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intravitreal (IVT) Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intravitreal (IVT) Injectables Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Intravitreal (IVT) Injectables Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Intravitreal (IVT) Injectables Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intravitreal (IVT) Injectables Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intravitreal (IVT) Injectables Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intravitreal (IVT) Injectables Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Intravitreal (IVT) Injectables Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Intravitreal (IVT) Injectables Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intravitreal (IVT) Injectables Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intravitreal (IVT) Injectables Sales (K Units) by Type (2020-2025)
 Table 51. Global Intravitreal (IVT) Injectables Sales (K Units) by Type (2026-2031)
 Table 52. Global Intravitreal (IVT) Injectables Sales Market Share by Type (2020-2025)
 Table 53. Global Intravitreal (IVT) Injectables Sales Market Share by Type (2026-2031)
 Table 54. Global Intravitreal (IVT) Injectables Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intravitreal (IVT) Injectables Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intravitreal (IVT) Injectables Revenue Market Share by Type (2020-2025)
 Table 57. Global Intravitreal (IVT) Injectables Revenue Market Share by Type (2026-2031)
 Table 58. Global Intravitreal (IVT) Injectables Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Intravitreal (IVT) Injectables Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Intravitreal (IVT) Injectables Sales (K Units) by Application (2020-2025)
 Table 61. Global Intravitreal (IVT) Injectables Sales (K Units) by Application (2026-2031)
 Table 62. Global Intravitreal (IVT) Injectables Sales Market Share by Application (2020-2025)
 Table 63. Global Intravitreal (IVT) Injectables Sales Market Share by Application (2026-2031)
 Table 64. Global Intravitreal (IVT) Injectables Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intravitreal (IVT) Injectables Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intravitreal (IVT) Injectables Revenue Market Share by Application (2020-2025)
 Table 67. Global Intravitreal (IVT) Injectables Revenue Market Share by Application (2026-2031)
 Table 68. Global Intravitreal (IVT) Injectables Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Intravitreal (IVT) Injectables Price (USD/Unit) by Application (2026-2031)
 Table 70. Regeneron Pharmaceuticals Company Information
 Table 71. Regeneron Pharmaceuticals Description and Business Overview
 Table 72. Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product
 Table 74. Regeneron Pharmaceuticals Recent Developments/Updates
 Table 75. Bausch & Lomb Company Information
 Table 76. Bausch & Lomb Description and Business Overview
 Table 77. Bausch & Lomb Intravitreal (IVT) Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Bausch & Lomb Intravitreal (IVT) Injectables Product
 Table 79. Bausch & Lomb Recent Developments/Updates
 Table 80. Novartis Company Information
 Table 81. Novartis Description and Business Overview
 Table 82. Novartis Intravitreal (IVT) Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis Intravitreal (IVT) Injectables Product
 Table 84. Novartis Recent Developments/Updates
 Table 85. Allergan Company Information
 Table 86. Allergan Description and Business Overview
 Table 87. Allergan Intravitreal (IVT) Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Allergan Intravitreal (IVT) Injectables Product
 Table 89. Allergan Recent Developments/Updates
 Table 90. Alimera Sciences Company Information
 Table 91. Alimera Sciences Description and Business Overview
 Table 92. Alimera Sciences Intravitreal (IVT) Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Alimera Sciences Intravitreal (IVT) Injectables Product
 Table 94. Alimera Sciences Recent Developments/Updates
 Table 95. ThromboGenics Company Information
 Table 96. ThromboGenics Description and Business Overview
 Table 97. ThromboGenics Intravitreal (IVT) Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. ThromboGenics Intravitreal (IVT) Injectables Product
 Table 99. ThromboGenics Recent Developments/Updates
 Table 100. Bristol-Myers Squibb Company Information
 Table 101. Bristol-Myers Squibb Description and Business Overview
 Table 102. Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Bristol-Myers Squibb Intravitreal (IVT) Injectables Product
 Table 104. Bristol-Myers Squibb Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Intravitreal (IVT) Injectables Distributors List
 Table 108. Intravitreal (IVT) Injectables Customers List
 Table 109. Intravitreal (IVT) Injectables Market Trends
 Table 110. Intravitreal (IVT) Injectables Market Drivers
 Table 111. Intravitreal (IVT) Injectables Market Challenges
 Table 112. Intravitreal (IVT) Injectables Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intravitreal (IVT) Injectables
 Figure 2. Global Intravitreal (IVT) Injectables Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intravitreal (IVT) Injectables Market Share by Type: 2024 & 2031
 Figure 4. Anti-VEGF Product Picture
 Figure 5. Corticosteroids Product Picture
 Figure 6. Antibiotics Product Picture
 Figure 7. Antivirals Product Picture
 Figure 8. Antifungals Product Picture
 Figure 9. Global Intravitreal (IVT) Injectables Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Intravitreal (IVT) Injectables Market Share by Application: 2024 & 2031
 Figure 11. Hospital Pharmacies
 Figure 12. Retail Pharmacies
 Figure 13. Drug Stores
 Figure 14. Mail Order Pharmacies
 Figure 15. Others
 Figure 16. Global Intravitreal (IVT) Injectables Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Intravitreal (IVT) Injectables Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Intravitreal (IVT) Injectables Sales (2020-2031) & (K Units)
 Figure 19. Global Intravitreal (IVT) Injectables Average Price (USD/Unit) & (2020-2031)
 Figure 20. Intravitreal (IVT) Injectables Report Years Considered
 Figure 21. Intravitreal (IVT) Injectables Sales Share by Manufacturers in 2024
 Figure 22. Global Intravitreal (IVT) Injectables Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Intravitreal (IVT) Injectables Players: Market Share by Revenue in Intravitreal (IVT) Injectables in 2024
 Figure 24. Intravitreal (IVT) Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Intravitreal (IVT) Injectables Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Intravitreal (IVT) Injectables Sales Market Share by Country (2020-2031)
 Figure 27. North America Intravitreal (IVT) Injectables Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Intravitreal (IVT) Injectables Sales Market Share by Country (2020-2031)
 Figure 31. Europe Intravitreal (IVT) Injectables Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Intravitreal (IVT) Injectables Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Intravitreal (IVT) Injectables Revenue Market Share by Region (2020-2031)
 Figure 39. China Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Intravitreal (IVT) Injectables Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Intravitreal (IVT) Injectables Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Intravitreal (IVT) Injectables Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Intravitreal (IVT) Injectables Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Intravitreal (IVT) Injectables Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Intravitreal (IVT) Injectables by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Intravitreal (IVT) Injectables by Type (2020-2031)
 Figure 61. Global Intravitreal (IVT) Injectables Price (USD/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Intravitreal (IVT) Injectables by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Intravitreal (IVT) Injectables by Application (2020-2031)
 Figure 64. Global Intravitreal (IVT) Injectables Price (USD/Unit) by Application (2020-2031)
 Figure 65. Intravitreal (IVT) Injectables Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Intravitreal Injection Market Research Report 2024
Global Intraocular Injections Market Research Report 2024
Global Intravitreal Injection of Anti VEGF Drugs Market Research Report 2024
Global Anti VEGF Intravitreal Drugs Market Research Report 2024
Global Implantable Ophthalmic Drugs Market Research Report 2025
Global Intravitreal Implant Market Research Report 2024
Global Ranibizumab Injection Market Research Report 2024
Global Injectable Regenerative Graft Market Research Report 2024
Global Retinal Vasculitis Treatment Market Research Report 2025
Ophthalmology Medical Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fluocinolone Acetonide Intravitreal Implant Market Research Report 2024
Ophthalmic Intraocular Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Retinal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High value Medical Consumables for Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravitreal Injectable Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Robotic Intravitreal Injection System Market Research Report 2024
Ophthalmology High value Medical Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High value Ophthalmic Medical Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cytomegalovirus Retinitis Treatment Market Research Report 2024
Global High Value Ophthalmic Consumables Market Research Report 2025

RELATED REPORTS

Global High Acuity Care Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5D18285
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global mHealth (Mobile Health) Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B6151
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Resin Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21S7871
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mobile Medical Imaging Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16Q6154
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions